Literature DB >> 1648151

Intrahepatic cholangiocarcinoma in hepatolithiasis: A frequently overlooked disease.

S M Sheen-Chen1, F F Chou, H L Eng.   

Abstract

Five cases of intrahepatic cholangiocarcinoma were found among 101 cases of hepatolithiasis. There was no definite sign of cholangiocarcinoma in ERCP and image studies of four cases. The possibility of the existence of occult cholangiocarcinoma should be kept in mind, especially when unusual presentations, such as body weight loss, anemia, palpable abdominal mass, and intractable pain, appear. An intraoperative frozen-section examination should be considered under the following circumstances: (1) whitish nodular mass over liver, (2) mucinous substance within bile duct, and (3) enlarged, firm lymph nodes clustered along the hepatic arteries and/or celiac arteries.

Entities:  

Mesh:

Year:  1991        PMID: 1648151     DOI: 10.1002/jso.2930470213

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  20 in total

1.  New development of biliary surgery in China.

Authors:  Qiang-Huang Zhi
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

2.  Cholangiocarcinoma in the distal bile duct: a probable etiologic association with choledocholithiasis.

Authors:  Masako Nishimura; Shigeyuki Naka; Kazuyoshi Hanazawa; Toru Tani; Masanobu Fukami; Shinta Okada; Yoshihide Fujiyama
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

3.  Outcomes of hepatectomy for hepatolithiasis.

Authors:  Tung-Yen Lee; Yao-Li Chen; Hung-Chi Chang; Chien-Pin Chan; Shou-Jen Kuo
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

4.  Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature.

Authors:  David G Perdue; Oliver W Cass; Carlos Milla; Jordan Dunitz; Jose Jessurun; Harvey L Sharp; Sarah J Schwarzenberg
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

5.  Progesterone receptor in patients with hepatolithiasis.

Authors:  S M Sheen-Chen; H T Ho; W J Chen; C W Sheen; H L Eng; F F Chou
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

6.  Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma.

Authors:  Qian D Zhu; Meng T Zhou; Qing Q Zhou; Hong Q Shi; Qi Y Zhang; Zheng P Yu
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

7.  Laparoscopy versus open left lateral segmentectomy for recurrent pyogenic cholangitis.

Authors:  C N Tang; C K Tai; J P Y Ha; W T Siu; K K Tsui; M K W Li
Journal:  Surg Endosc       Date:  2005-07-28       Impact factor: 4.584

8.  Intrahepatic stones. The transhepatic team approach.

Authors:  H A Pitt; A C Venbrux; J Coleman; C A Prescott; M S Johnson; F A Osterman; J L Cameron
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

9.  Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.

Authors:  Hyo Jung Kim; Jae Seon Kim; Sang Jun Suh; Beom Jae Lee; Jong-Jae Park; Hong Sik Lee; Chang Duck Kim; Young-Tae Bak
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

Review 10.  Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.

Authors:  Hyo Jung Kim; Jae Seon Kim; Moon Kyung Joo; Beom Jae Lee; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Kwan Soo Byun; Young-Tae Bak
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.